Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects

Published:2020-07-03 Issue: Volume: Page:
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Rosskopf Konrad¹^ORCID,Helmberg Wolfgang¹,Schlenke Peter¹

Affiliation:

1. Department of Blood Group Serology and Transfusion MedicineMedical University Graz and LKH‐Univ.Klinikum Graz Graz Austria

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15926

Reference28 articles.

1. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland

2. Pathogen Inactivation Technologies for Cellular Blood Components: an Update

3. A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen– UVA photochemical treatment

4. Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma

5. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Pathogen Reduction Technology—Should We Stay or Should We Go…?;Journal of Clinical Medicine;2024-09-10

2. Impact of Shelf-Life Extension on Platelet Availability: Results from an Inventory Management Modeling Study;Transfusion Medicine and Hemotherapy;2024-04-02

3. A Call to Reinvent Platelet Products;Transfusion Medicine and Hemotherapy;2024

4. Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT ^TMBlood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience;BLOOD TRANSFUS-ITALY;2023

5. Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011–2020);Transfusion Medicine and Hemotherapy;2022-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3